Zenas BioPharma director reports no share holdings

A newly reported director of Zenas BioPharma has filed an initial Form 3 with no holdings or transactions disclosed.

Rhea-AI Filing Summary

Zenas BioPharma, Inc. (ZBIO) reports that Christy J. Oliger has filed an initial statement of beneficial ownership on Form 3 in the capacity of director. The filing lists no equity holdings or reportable transactions and notes an Exhibit 24 Power of Attorney authorizing filing actions.

Key Terms

Form 3, beneficial ownership, director, Power of Attorney

4 terms

Form 3 regulatory

"has filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"has filed an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

director regulatory

"Christy J. Oliger has filed an initial statement of beneficial ownership in the capacity of director"

Power of Attorney regulatory

"notes an Exhibit 24 Power of Attorney authorizing filing actions"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for ZBIO disclose about Christy J. Oliger?

It states that Christy J. Oliger is a director of Zenas BioPharma, Inc. (ZBIO) and is filing an initial statement of beneficial ownership. The Form 3 does not list any securities holdings or reportable transactions.

Does the ZBIO Form 3 show any shares owned or trades by the director?

No. The Form 3 for ZBIO reports no transactions and shows no securities holdings or derivative positions for director Christy J. Oliger as of the filing.

What role does Christy J. Oliger have at Zenas BioPharma (ZBIO)?

The Form 3 identifies Christy J. Oliger as a director of Zenas BioPharma, Inc. There is no indication that this reporting person is an officer or ten percent owner.

Is there any Rule 10b5-1 trading plan mentioned in the ZBIO Form 3?

No. The Form 3 data show no Rule 10b5-1 trading plan affirmation and there are no reported transactions that would be associated with such a plan.

What additional document is referenced in the ZBIO Form 3?

The Form 3 remarks reference an Exhibit 24 - Power of Attorney, which authorizes certain filing actions on behalf of the reporting person. No further details are provided in the summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:01 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Oliger Christy J.

(Last) (First) (Middle)

C/O ZENAS BIOPHARMA, INC.

852 WINTER ST., SUITE 250

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2026

3. Issuer Name and Ticker or Trading Symbol
Zenas BioPharma, Inc. [ ZBIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	By: /s/ Chase Jayasekera, Attorney-in-Fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)